URGN Operating Cash Flow (Statement)
Urogen Pharma Ltd · Operating Cash Flow (Statement)
URGN Operating Cash Flow (Statement)
Latest reported-$158.92Mperiod ending
URGN Cash from Operations (-$2.56M → -$158.92M)
Annual operating cash flow (statement)
High-resolution chart · PNG
URGN operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -162,444,000 | |
| -96,766,000 | |
| -76,376,000 | |
| -87,559,000 | |
| -84,892,000 | |
| -105,886,000 | |
| -71,017,000 | |
| -37,334,000 | |
| -9,571,000 | |
| 4,189,000 | |
| -7,175,000 | |
| -4,117,000 | |
| -2,557,000 |